Soulbrain Co., Ltd. Stock

Equities

A357780

KR7357780006

Specialty Chemicals

End-of-day quote Korea S.E. 06:00:00 2024-04-24 pm EDT 5-day change 1st Jan Change
288,500 KRW -1.03% Intraday chart for Soulbrain Co., Ltd. -4.47% -5.10%
Sales 2024 * 913B 664M Sales 2025 * 1,078B 784M Capitalization 2,234B 1.62B
Net income 2024 * 155B 113M Net income 2025 * 195B 142M EV / Sales 2024 * 2.22 x
Net cash position 2024 * 204B 148M Net cash position 2025 * 408B 296M EV / Sales 2025 * 1.69 x
P/E ratio 2024 *
14.5 x
P/E ratio 2025 *
11.5 x
Employees 1,233
Yield 2024 *
0.7%
Yield 2025 *
0.73%
Free-Float 48.77%
More Fundamentals * Assessed data
Dynamic Chart
Nomura Adjusts Soulbrain’s Price Target to KRW380,000 From KRW350,000, Keeps at Buy MT
Nomura Adjusts SoulBrain's Price Target to KRW350,000 From KRW310,000, Keeps at Buy MT
Tranche Update on Soulbrain Co., Ltd.'s Equity Buyback Plan announced on September 29, 2022. CI
Tranche Update on Soulbrain Co., Ltd.'s Equity Buyback Plan announced on September 29, 2022. CI
Soulbrain Co., Ltd.'s Equity Buyback announced on September 29, 2022 has expired with 22,994 shares, representing 0.3% for KRW 4,995.12 million. CI
Soulbrain Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Tranche Update on Soulbrain Co., Ltd.'s Equity Buyback Plan announced on September 29, 2022. CI
Soulbrain Co., Ltd. announces an Equity Buyback for KRW 5,000 million worth of its shares. CI
Soulbrain Co., Ltd. authorizes a Buyback Plan. CI
Nomura Adjusts Soulbrain's Price Target to 310,000 Won From 350,000 Won, Keeps at Buy MT
Soulbrain Co., Ltd. completed the acquisition of additional 39% stake in Fect Co., Ltd. from Stella Chemifa Corporation. CI
Soulbrain Co., Ltd. signed a share transfer agreement to acquire additional 39% stake in Fect Co., Ltd. from Stella Chemifa Corporation. CI
Nomura Adjusts Soulbrain’s Price Target to 350,000 Won From 400,000 Won, Keeps at Buy MT
Soulbrain Holdings Co., Ltd. completed the acquisition of an additional 27.98% stake in Soulbrain Co., Ltd. (KOSDAQ : A357780) for approximately KRW 500 million. CI
Soulbrain Holdings Co., Ltd. made an offer to acquire an additional 38.57% stake in Soulbrain Co., Ltd. (KOSDAQ : A357780) for approximately KRW 690 million. CI
More news
1 day-1.03%
1 week-4.47%
Current month-7.68%
1 month-2.70%
3 months-4.94%
6 months+17.52%
Current year-5.10%
More quotes
1 week
279 500.00
Extreme 279500
300 000.00
1 month
279 500.00
Extreme 279500
321 000.00
Current year
262 000.00
Extreme 262000
322 000.00
1 year
207 000.00
Extreme 207000
322 000.00
3 years
176 200.00
Extreme 176200
372 600.00
5 years
176 200.00
Extreme 176200
372 600.00
10 years
176 200.00
Extreme 176200
372 600.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 64 -
Chief Tech/Sci/R&D Officer 50 -
Chief Tech/Sci/R&D Officer 60 -
Members of the board TitleAgeSince
Chief Executive Officer 64 -
Director/Board Member 75 19-12-31
Director/Board Member 69 23-03-28
More insiders
Date Price Change Volume
24-04-25 288,500 -1.03% 17,581
24-04-24 291,500 +3.00% 26,670
24-04-23 283,000 -1.74% 18,799
24-04-22 288,000 -3.19% 55,148
24-04-19 297,500 -1.49% 41,431

End-of-day quote Korea S.E., April 24, 2024

More quotes
Soulbrain Co Ltd is a Korea-based company mainly engaged in the manufacture and sale of information and technology (IT) materials. The Company is engaged in the semiconductor materials business, display materials business, secondary battery materials business, electronic materials business, and bio-health care business. The semiconductor materials business manufactures and sells semiconductor materials such as etching and cleaning solutions. The display materials business produces and supplies major parts for panels such as thin glasses. The secondary battery materials business produces electrolytes and lead tabs, and is also engaged in the development of mid-to-large-sized battery materials. The electronic materials business mainly develops and produces electronic materials necessary for the process of solar power generation, and electric vehicles. The bio-healthcare business mainly produces and sells cell therapy products and bio-materials necessary for the cosmetics business.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
288,500 KRW
Average target price
370,000 KRW
Spread / Average Target
+28.25%
Consensus
  1. Stock Market
  2. Equities
  3. A357780 Stock